| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mitochondria | 8 | 2012 | 763 | 1.450 |
Why?
|
| Reactive Oxygen Species | 10 | 2016 | 513 | 1.290 |
Why?
|
| Glycolysis | 7 | 2018 | 173 | 1.070 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 | 2016 | 178 | 0.980 |
Why?
|
| Tumor Suppressor Protein p53 | 6 | 2016 | 738 | 0.980 |
Why?
|
| Amino Acid Transport Systems, Neutral | 1 | 2025 | 14 | 0.930 |
Why?
|
| Glutathione | 6 | 2016 | 196 | 0.920 |
Why?
|
| Organic Anion Transporters | 1 | 2025 | 23 | 0.920 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2025 | 36 | 0.910 |
Why?
|
| Thyroid Hormones | 1 | 2025 | 56 | 0.900 |
Why?
|
| Isothiocyanates | 3 | 2016 | 12 | 0.900 |
Why?
|
| Antineoplastic Agents | 9 | 2023 | 1802 | 0.880 |
Why?
|
| Neoplasms | 11 | 2023 | 2955 | 0.830 |
Why?
|
| Stromal Cells | 3 | 2013 | 315 | 0.700 |
Why?
|
| Pancreatic Neoplasms | 6 | 2024 | 728 | 0.590 |
Why?
|
| Oxidation-Reduction | 6 | 2014 | 435 | 0.580 |
Why?
|
| Cell Survival | 8 | 2012 | 850 | 0.530 |
Why?
|
| Organelle Biogenesis | 1 | 2016 | 19 | 0.510 |
Why?
|
| Chromosome Deletion | 2 | 2016 | 649 | 0.500 |
Why?
|
| Apoptosis | 8 | 2013 | 1852 | 0.400 |
Why?
|
| Cell Communication | 2 | 2012 | 195 | 0.400 |
Why?
|
| Drug Resistance, Neoplasm | 5 | 2023 | 819 | 0.400 |
Why?
|
| Brain | 1 | 2025 | 3161 | 0.390 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2014 | 611 | 0.370 |
Why?
|
| Mutation | 7 | 2025 | 6144 | 0.370 |
Why?
|
| Cystine | 1 | 2012 | 16 | 0.370 |
Why?
|
| NADPH Oxidases | 1 | 2012 | 108 | 0.360 |
Why?
|
| DNA, Mitochondrial | 4 | 2009 | 244 | 0.350 |
Why?
|
| Bone Marrow Cells | 1 | 2012 | 246 | 0.330 |
Why?
|
| Glutamine | 1 | 2011 | 201 | 0.320 |
Why?
|
| Energy Metabolism | 3 | 2018 | 784 | 0.310 |
Why?
|
| Lignans | 1 | 2009 | 7 | 0.300 |
Why?
|
| Pyruvates | 1 | 2009 | 18 | 0.300 |
Why?
|
| Hexokinase | 1 | 2009 | 25 | 0.300 |
Why?
|
| HEK293 Cells | 3 | 2025 | 802 | 0.300 |
Why?
|
| Biphenyl Compounds | 1 | 2009 | 74 | 0.290 |
Why?
|
| Reactive Nitrogen Species | 1 | 2008 | 8 | 0.290 |
Why?
|
| Carcinogens | 2 | 2008 | 128 | 0.290 |
Why?
|
| Drug Delivery Systems | 1 | 2009 | 211 | 0.290 |
Why?
|
| Nitrosamines | 1 | 2008 | 15 | 0.280 |
Why?
|
| Leukemia | 1 | 2011 | 374 | 0.280 |
Why?
|
| Cell Respiration | 3 | 2016 | 24 | 0.280 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2024 | 176 | 0.280 |
Why?
|
| Animals | 18 | 2025 | 34278 | 0.280 |
Why?
|
| Radiation Tolerance | 1 | 2008 | 59 | 0.270 |
Why?
|
| Esophagus | 1 | 2009 | 237 | 0.260 |
Why?
|
| Epithelial Cells | 2 | 2009 | 895 | 0.260 |
Why?
|
| Bile Acids and Salts | 1 | 2009 | 258 | 0.250 |
Why?
|
| Chalcones | 1 | 2006 | 5 | 0.250 |
Why?
|
| Cell Line, Tumor | 10 | 2018 | 3642 | 0.240 |
Why?
|
| Boron Compounds | 1 | 2006 | 35 | 0.240 |
Why?
|
| Proteasome Inhibitors | 1 | 2006 | 57 | 0.240 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2024 | 173 | 0.240 |
Why?
|
| RNA, Small Interfering | 5 | 2012 | 666 | 0.230 |
Why?
|
| Triiodothyronine | 1 | 2025 | 56 | 0.230 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2005 | 85 | 0.230 |
Why?
|
| Signal Transduction | 5 | 2014 | 4645 | 0.230 |
Why?
|
| Thyroxine | 1 | 2025 | 62 | 0.230 |
Why?
|
| Humans | 31 | 2025 | 130931 | 0.220 |
Why?
|
| Symporters | 1 | 2025 | 74 | 0.220 |
Why?
|
| DNA Damage | 2 | 2005 | 523 | 0.220 |
Why?
|
| Biological Transport | 1 | 2025 | 332 | 0.220 |
Why?
|
| Muscular Atrophy | 1 | 2025 | 76 | 0.220 |
Why?
|
| Blood-Brain Barrier | 1 | 2025 | 147 | 0.220 |
Why?
|
| Esophageal Neoplasms | 1 | 2009 | 389 | 0.220 |
Why?
|
| Muscle Hypotonia | 1 | 2025 | 194 | 0.210 |
Why?
|
| Genomic Instability | 1 | 2005 | 249 | 0.210 |
Why?
|
| Cryoelectron Microscopy | 1 | 2025 | 238 | 0.200 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2024 | 76 | 0.200 |
Why?
|
| Heat Shock Transcription Factors | 1 | 2023 | 21 | 0.200 |
Why?
|
| Proteostasis | 1 | 2023 | 35 | 0.200 |
Why?
|
| Endoribonucleases | 1 | 2023 | 84 | 0.200 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2023 | 137 | 0.190 |
Why?
|
| Models, Molecular | 1 | 2025 | 1084 | 0.180 |
Why?
|
| Adenocarcinoma | 3 | 2014 | 991 | 0.180 |
Why?
|
| Lung Neoplasms | 2 | 2024 | 1527 | 0.170 |
Why?
|
| Mice | 11 | 2024 | 18410 | 0.170 |
Why?
|
| Oxidative Phosphorylation | 2 | 2012 | 129 | 0.170 |
Why?
|
| Enzyme Inhibitors | 1 | 2023 | 565 | 0.170 |
Why?
|
| HL-60 Cells | 2 | 2011 | 33 | 0.170 |
Why?
|
| Immunoblotting | 4 | 2016 | 291 | 0.160 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2018 | 1975 | 0.160 |
Why?
|
| Superoxide Dismutase | 2 | 2012 | 172 | 0.150 |
Why?
|
| Oncogenes | 2 | 2011 | 164 | 0.150 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2018 | 66 | 0.140 |
Why?
|
| Transfection | 3 | 2012 | 960 | 0.140 |
Why?
|
| Flow Cytometry | 3 | 2012 | 768 | 0.140 |
Why?
|
| Neoplastic Stem Cells | 2 | 2011 | 330 | 0.140 |
Why?
|
| Boronic Acids | 3 | 2006 | 49 | 0.130 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2016 | 18 | 0.130 |
Why?
|
| Peroxiredoxins | 1 | 2016 | 10 | 0.130 |
Why?
|
| Sirtuin 2 | 1 | 2016 | 11 | 0.130 |
Why?
|
| mRNA Cleavage and Polyadenylation Factors | 1 | 2016 | 6 | 0.120 |
Why?
|
| Glutaminase | 1 | 2016 | 17 | 0.120 |
Why?
|
| Mice, Nude | 3 | 2013 | 715 | 0.120 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2018 | 486 | 0.120 |
Why?
|
| Cell Line | 2 | 2012 | 2596 | 0.110 |
Why?
|
| Enzyme Activation | 3 | 2012 | 586 | 0.110 |
Why?
|
| Models, Biological | 2 | 2011 | 1389 | 0.110 |
Why?
|
| Endoplasmic Reticulum | 2 | 2005 | 208 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2016 | 364 | 0.110 |
Why?
|
| Deoxycytidine | 1 | 2014 | 82 | 0.110 |
Why?
|
| Genes, ras | 1 | 2014 | 99 | 0.110 |
Why?
|
| Cell Death | 2 | 2018 | 237 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2014 | 115 | 0.100 |
Why?
|
| RNA, Long Noncoding | 1 | 2016 | 229 | 0.100 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2014 | 999 | 0.100 |
Why?
|
| Tumor Cells, Cultured | 2 | 2012 | 989 | 0.100 |
Why?
|
| NADPH Oxidase 1 | 1 | 2012 | 2 | 0.090 |
Why?
|
| Interleukin-1beta | 1 | 2013 | 159 | 0.090 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2012 | 26 | 0.090 |
Why?
|
| Down-Regulation | 1 | 2014 | 660 | 0.090 |
Why?
|
| Tetracycline | 1 | 2012 | 75 | 0.090 |
Why?
|
| Organoplatinum Compounds | 1 | 2012 | 33 | 0.090 |
Why?
|
| HCT116 Cells | 2 | 2016 | 60 | 0.090 |
Why?
|
| Culture Media, Conditioned | 1 | 2012 | 83 | 0.090 |
Why?
|
| NADH Dehydrogenase | 1 | 2011 | 5 | 0.090 |
Why?
|
| Vidarabine | 1 | 2012 | 90 | 0.090 |
Why?
|
| Buthionine Sulfoximine | 1 | 2011 | 9 | 0.090 |
Why?
|
| Molecular Weight | 1 | 2012 | 298 | 0.090 |
Why?
|
| Genes, Neoplasm | 1 | 2012 | 80 | 0.090 |
Why?
|
| Electron Transport Complex I | 1 | 2011 | 32 | 0.090 |
Why?
|
| Blotting, Western | 2 | 2012 | 1018 | 0.090 |
Why?
|
| Coculture Techniques | 1 | 2012 | 234 | 0.090 |
Why?
|
| Carcinogenesis | 1 | 2014 | 352 | 0.090 |
Why?
|
| Immunoprecipitation | 2 | 2016 | 190 | 0.090 |
Why?
|
| Cysteine | 1 | 2012 | 139 | 0.090 |
Why?
|
| Plasmids | 1 | 2012 | 455 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 379 | 0.090 |
Why?
|
| Melanoma | 1 | 2018 | 911 | 0.080 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2018 | 942 | 0.080 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2011 | 198 | 0.080 |
Why?
|
| Carcinoma | 1 | 2013 | 283 | 0.080 |
Why?
|
| Membrane Potentials | 1 | 2011 | 297 | 0.080 |
Why?
|
| Allyl Compounds | 1 | 2009 | 4 | 0.080 |
Why?
|
| Cyclophilins | 1 | 2009 | 19 | 0.080 |
Why?
|
| Cell Line, Transformed | 1 | 2009 | 159 | 0.070 |
Why?
|
| T-Lymphocytes | 1 | 2018 | 1768 | 0.070 |
Why?
|
| Fibroblasts | 1 | 2013 | 861 | 0.070 |
Why?
|
| Ovarian Neoplasms | 1 | 2013 | 456 | 0.070 |
Why?
|
| Phenols | 1 | 2009 | 72 | 0.070 |
Why?
|
| Ubiquitin | 2 | 2006 | 131 | 0.070 |
Why?
|
| Pyrazines | 2 | 2005 | 78 | 0.070 |
Why?
|
| Nitric Oxide | 1 | 2011 | 468 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 2 | 2006 | 80 | 0.070 |
Why?
|
| Mice, Knockout | 1 | 2016 | 3850 | 0.070 |
Why?
|
| Radiation, Ionizing | 1 | 2008 | 39 | 0.070 |
Why?
|
| Thioredoxins | 1 | 2008 | 25 | 0.070 |
Why?
|
| Oxygen Consumption | 1 | 2009 | 303 | 0.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2009 | 239 | 0.070 |
Why?
|
| Bronchi | 1 | 2008 | 103 | 0.070 |
Why?
|
| Adaptation, Physiological | 1 | 2009 | 261 | 0.070 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2006 | 26 | 0.060 |
Why?
|
| Tumor Microenvironment | 1 | 2011 | 693 | 0.060 |
Why?
|
| DNA Polymerase gamma | 1 | 2005 | 17 | 0.060 |
Why?
|
| eIF-2 Kinase | 1 | 2005 | 35 | 0.060 |
Why?
|
| Lymphoma | 1 | 2009 | 327 | 0.060 |
Why?
|
| Antioxidants | 1 | 2008 | 334 | 0.060 |
Why?
|
| Molecular Structure | 1 | 2006 | 320 | 0.060 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2006 | 237 | 0.060 |
Why?
|
| Base Sequence | 1 | 2009 | 2781 | 0.060 |
Why?
|
| DNA Primers | 1 | 2005 | 609 | 0.050 |
Why?
|
| Disease Progression | 1 | 2011 | 2191 | 0.050 |
Why?
|
| Piperidines | 1 | 2006 | 230 | 0.050 |
Why?
|
| Homeostasis | 1 | 2008 | 713 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2006 | 484 | 0.050 |
Why?
|
| Calcium | 2 | 2005 | 1040 | 0.050 |
Why?
|
| Metalloendopeptidases | 1 | 2024 | 101 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 2636 | 0.050 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2024 | 123 | 0.050 |
Why?
|
| Colonic Neoplasms | 1 | 2006 | 262 | 0.050 |
Why?
|
| Gene Silencing | 2 | 2014 | 228 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 1490 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 1614 | 0.050 |
Why?
|
| Neoplasms, Experimental | 1 | 2002 | 206 | 0.040 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2018 | 8 | 0.040 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2018 | 14 | 0.040 |
Why?
|
| Lipid Peroxidation | 1 | 2018 | 90 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2005 | 1348 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2002 | 704 | 0.030 |
Why?
|
| Chemokine CXCL10 | 1 | 2018 | 52 | 0.030 |
Why?
|
| Ubiquitination | 1 | 2018 | 171 | 0.030 |
Why?
|
| Oxidative Stress | 2 | 2016 | 798 | 0.030 |
Why?
|
| Comet Assay | 1 | 2016 | 7 | 0.030 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2016 | 41 | 0.030 |
Why?
|
| Oxidants | 1 | 2016 | 24 | 0.030 |
Why?
|
| Peroxidase | 1 | 2016 | 62 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2014 | 2459 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2002 | 1227 | 0.030 |
Why?
|
| Thapsigargin | 2 | 2005 | 21 | 0.030 |
Why?
|
| Caspase Inhibitors | 2 | 2005 | 32 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2024 | 2095 | 0.030 |
Why?
|
| RNA Precursors | 1 | 2016 | 43 | 0.030 |
Why?
|
| Bortezomib | 2 | 2005 | 73 | 0.030 |
Why?
|
| Caspases | 2 | 2005 | 156 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2016 | 362 | 0.030 |
Why?
|
| Histones | 1 | 2018 | 515 | 0.030 |
Why?
|
| Prognosis | 1 | 2024 | 4930 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2014 | 301 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2016 | 305 | 0.030 |
Why?
|
| Zebrafish | 1 | 2016 | 422 | 0.030 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2014 | 128 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2014 | 579 | 0.030 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2013 | 25 | 0.020 |
Why?
|
| Transcription Factor RelA | 1 | 2013 | 51 | 0.020 |
Why?
|
| RNA Interference | 1 | 2014 | 497 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2013 | 136 | 0.020 |
Why?
|
| Paracrine Communication | 1 | 2013 | 69 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2018 | 4738 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2018 | 2965 | 0.020 |
Why?
|
| Chemokines | 1 | 2013 | 127 | 0.020 |
Why?
|
| Phosphorylation | 2 | 2006 | 1565 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2014 | 442 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2013 | 363 | 0.020 |
Why?
|
| Cellular Senescence | 1 | 2014 | 221 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2013 | 238 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 703 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2013 | 415 | 0.020 |
Why?
|
| Alleles | 1 | 2016 | 1705 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 1068 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2016 | 2575 | 0.020 |
Why?
|
| Female | 4 | 2018 | 70755 | 0.020 |
Why?
|
| NAD | 1 | 2006 | 50 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2006 | 86 | 0.020 |
Why?
|
| Tunicamycin | 1 | 2005 | 8 | 0.020 |
Why?
|
| Transcription Factor CHOP | 1 | 2005 | 4 | 0.020 |
Why?
|
| Cycloheximide | 1 | 2005 | 41 | 0.020 |
Why?
|
| Caspases, Initiator | 1 | 2005 | 5 | 0.020 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2005 | 34 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2005 | 51 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2005 | 85 | 0.010 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2006 | 253 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2005 | 241 | 0.010 |
Why?
|
| Molecular Chaperones | 1 | 2005 | 172 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2006 | 345 | 0.010 |
Why?
|
| Heat-Shock Proteins | 1 | 2005 | 179 | 0.010 |
Why?
|
| Pancreas | 1 | 2005 | 219 | 0.010 |
Why?
|
| Cisplatin | 1 | 2005 | 284 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2005 | 353 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2005 | 1018 | 0.010 |
Why?
|
| Cyclin A | 1 | 2002 | 17 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2005 | 579 | 0.010 |
Why?
|
| Period Circadian Proteins | 1 | 2002 | 25 | 0.010 |
Why?
|
| Gamma Rays | 1 | 2002 | 42 | 0.010 |
Why?
|
| Dimerization | 1 | 2002 | 139 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2002 | 236 | 0.010 |
Why?
|
| ARNTL Transcription Factors | 1 | 2002 | 46 | 0.010 |
Why?
|
| Thymus Gland | 1 | 2002 | 102 | 0.010 |
Why?
|
| Cyclin D1 | 1 | 2002 | 110 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 6862 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2002 | 194 | 0.010 |
Why?
|
| Cell Division | 1 | 2002 | 723 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2002 | 600 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2002 | 1217 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 598 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 10040 | 0.010 |
Why?
|
| Male | 2 | 2018 | 64823 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2002 | 1123 | 0.010 |
Why?
|
| Aged | 1 | 2013 | 21134 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2005 | 2558 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2002 | 2430 | 0.010 |
Why?
|
| Phenotype | 1 | 2002 | 4493 | 0.010 |
Why?
|
| Middle Aged | 1 | 2013 | 28735 | 0.010 |
Why?
|
| Time Factors | 1 | 2002 | 6275 | 0.010 |
Why?
|
| Adult | 1 | 2013 | 31541 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2002 | 3397 | 0.010 |
Why?
|